Already have an ACS ID? Log in
Renew your membership, and continue to enjoy these benefits.
Already an ACS Member? Log in here
Choose the membership that is right for you. Discount will be applied automatically at checkout.
Enjoy these benefits no matter which membership you pick.
Most Popular in Business
Dendreon will cut 600 jobs, or roughly 40% of its workforce, and close its Morris Plains, N.J., manufacturing facility in an attempt to save roughly $150 million annually. Dendreon has struggled to become profitable since the 2010 approval of its prostate cancer immunotherapy, Provenge. Sales of Provenge totaled $80 million in the second quarter, down 2.4% from the first quarter, and the drug is expected to face fierce competition from new products in the coming months. Dendreon shed 500 workers in September 2011.
This article has been sent to the following recipient: